Inflammatory cytokines activate indoleamine 2,3-dioxygenase (IDO) via signaling pathways such as STAT1α, IRF-1, p38 MAPK, and NF-κB, driving this metabolic shift and contributing to neurotransmitter dysfunction linked to depression (95–97). This evidence concerns the gene NFKB1 and depressive symptom measurement.